Amanote Research
Register
Sign In
Pseudotyping HIV Vector With the Spike Envelope Protein of SARS-CoV for Studying Viral Tropism, Immunology and Gene Therapy Applications
Molecular Therapy
- United States
doi 10.1016/j.ymthe.2004.06.305
Full Text
Open PDF
Abstract
Available in
full text
Categories
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Date
May 1, 2004
Authors
Unknown
Publisher
Elsevier BV
Related search
Monoclonal Antibodies for the S2 Subunit of Spike of SARS-CoV Cross-React With the Newly-Emerged SARS-CoV-2
Differential Antibody Recognition by Novel SARS-CoV-2 and SARS-CoV Spike Protein Receptor Binding Domains: Mechanistic Insights
In Silico Study of the Spike Protein From SARS-CoV-2 Interaction With ACE2: Similarity With SARS-CoV, Hot-Spot Analysis and Effect of the Receptor Polymorphism
The First-In-Class Peptide Binder to the SARS-CoV-2 Spike Protein
On the Interactions of the Receptor-Binding Domain of SARS-CoV-1 and SARS-CoV-2 Spike Proteins With Monoclonal Antibodies and the Receptor ACE2
SARS-CoV-2 Invades Host Cells via a Novel Route: CD147-spike Protein
Distinct Structural Flexibility Within SARS-CoV-2 Spike Protein Reveals Potential Therapeutic Targets
Deducing the N- And O- Glycosylation Profile of the Spike Protein of Novel Coronavirus SARS-CoV-2
Distinct Viral Clades of SARS‐CoV‐2: Implications for Modeling of Viral Spread
Journal of Medical Virology
Virology
Infectious Diseases
